Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher	pref label
tabling member	label

Search

1141362

	human indexable
	published
	registered interest
	answer date	25/07/2019
	date	23/07/2019
	date tabled	23/07/2019
	ddp created	23/07/2019 16:59:17
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	24/07/2019 15:15:31 05/08/2019 12:04:07
	hansard heading	Measles
	house id	1
	identifier	280995
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/08/2019 11:32:33
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has published on distinguishing between rashes caused by the measles vaccine and those arising from the wild strain of measles.
	session	2017/19
	session number	1
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	title	House of Commons Tabled Parliamentary Question 2017/19 280995
	type	WrittenParliamentaryQuestion
	uin	280995
	version	2
	written parliamentary question type	Ordinary
	answer	answer
	creator	1522 label Biography information for Adam Holloway
	publisher	25259 pref label House of Commons
	tabling member	1522 label Biography information for Adam Holloway

1141363

	human indexable
	published
	registered interest
	answer date	25/07/2019
	date	23/07/2019
	date tabled	23/07/2019
	ddp created	23/07/2019 16:59:19
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2019 17:09:26 05/08/2019 12:04:06
	hansard heading	Measles
	house id	1
	identifier	280996
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/08/2019 11:32:33
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that statistics on the infection rate for measles do not include people who have received the live measles vaccine and contracted a measles-like rash and fever.
	session	2017/19
	session number	1
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	title	House of Commons Tabled Parliamentary Question 2017/19 280996
	type	WrittenParliamentaryQuestion
	uin	280996
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1522 label Biography information for Adam Holloway
	publisher	25259 pref label House of Commons
	tabling member	1522 label Biography information for Adam Holloway

1141364

	human indexable
	published
	registered interest
	answer date	25/07/2019
	date	23/07/2019
	date tabled	23/07/2019
	ddp created	23/07/2019 16:59:22
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2019 17:09:28 05/08/2019 12:04:04
	hansard heading	MMR Vaccine: Side Effects
	house id	1
	identifier	280997
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	05/08/2019 11:34:01
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that (a) body inclusion encephalitis and (b) other adverse events experienced after a measles vaccine are identified in a timely way by healthcare professionals.
	session	2017/19
	session number	1
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	title	House of Commons Tabled Parliamentary Question 2017/19 280997
	type	WrittenParliamentaryQuestion
	uin	280997
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1522 label Biography information for Adam Holloway
	publisher	25259 pref label House of Commons
	tabling member	1522 label Biography information for Adam Holloway

1141380

	human indexable
	published
	registered interest
	answer date	25/07/2019
	date	23/07/2019
	date tabled	23/07/2019
	ddp created	23/07/2019 17:00:00
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2019 17:10:05 25/07/2019 17:07:10
	hansard heading	MMR Vaccine: Safety
	house id	1
	identifier	280998
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	25/07/2019 16:35:38
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to maintain and improve pharmacovigilance in relation to the MMR vaccine.
	session	2017/19
	session number	1
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	title	House of Commons Tabled Parliamentary Question 2017/19 280998
	type	WrittenParliamentaryQuestion
	uin	280998
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1522 label Biography information for Adam Holloway
	publisher	25259 pref label House of Commons
	tabling member	1522 label Biography information for Adam Holloway

1141381

	human indexable
	published
	registered interest
	answer date	25/07/2019
	date	23/07/2019
	date tabled	23/07/2019
	ddp created	23/07/2019 17:00:03
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/07/2019 17:10:07 25/07/2019 17:10:01
	hansard heading	MMR Vaccine
	house id	1
	identifier	280999
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	25/07/2019 16:38:57
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure (a) transparency and (b) accountability in the process of manufacturing the MMR vaccine.
	session	2017/19
	session number	1
	tabling member constituency	Gravesham
	tabling member printed	Adam Holloway
	title	House of Commons Tabled Parliamentary Question 2017/19 280999
	type	WrittenParliamentaryQuestion
	uin	280999
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1522 label Biography information for Adam Holloway
	publisher	25259 pref label House of Commons
	tabling member	1522 label Biography information for Adam Holloway